| 1. |
PDE4 inhibition in inflammatory lung disease |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1414,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 2. |
What lies ahead for oral vaccine delivery? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1414,
2003,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 3. |
Neonates whose mothers receive intrapartum antibacterials to prevent neonatal group B streptococcal infections are no more likely to receive antibacterials or undergo invasive procedures |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1414,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 4. |
Budesonide/formoterol proves its worth in COPD |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1414,
2003,
Page 5-5
&NA;,
Preview
|
|
摘要:
Chronic obstructive pulmonary disease (COPD) is a widespread, progressive disorder associated with episodes of worsening symptoms and recurrent exacerbations. High morbidity related to COPD takes its toll on patients' QOL, while inpatient mortality of 6−26% is associated with acute exacerbations. Thus, COPD represents one of the leading causes of morbidity and morality worldwide, and exerts a sizeable impact on individuals, societies and healthcare budgets. In addition, unlike other diseases which seem to affect less well-off countries, the impact of COPD is most profoundly felt in wealthier countries, such as the US and Canada. Preventing acute exacerbations and improving patients' QOL is a major aim of COPD management. Another pertinent consideration concerning COPD management is the allocation of healthcare resources, making the examination of costs and outcomes for different therapies of great importance to healthcare payers. These issues were investigated by researchers in two studies presented at a poster session at the 13th Annual Congress of the European Respiratory Society (ERS) [September−October 2003; Vienna, Austria].
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 5. |
New system cost effective in recipients of blood transfusion |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1414,
2003,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 6. |
DX 619: a new quinolone antibacterial is revealed |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1414,
2003,
Page 7-8
P Hunter,
Preview
|
|
摘要:
A number of posters presented at the 43rd Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) [Chicago, US; September 2003] described the properties of DX 619, a new quinolone antibacterial lacking a 6-F group. A number of preclinical studies presented at the meeting showed that DX 619 has good activity against a range of drug-resistant Gram-positive cocci, is effective in various animal models and has low phototoxicity and genotoxicity. Of particular note was the activity of DX 619 against staphylococci with reduced susceptibility or resistance to vancomycin.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 7. |
Modified PBMCs stimulate endothelial repair after injury |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1414,
2003,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 8. |
Cinacalcet*appears promising in patients with secondary hyperparathyroidism associated with chronic kidney disease, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1414,
2003,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 9. |
CC 5013*shows promise in the treatment of patients with myelodysplastic syndrome |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1414,
2003,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 10. |
Gemcitabine combination effective in heart transplantation model |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1414,
2003,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
首页
